2022_Dec_DDL_Edinburgh_leaderboard

Beyond Air

Beyond Air is developing a nitric oxide (NO) generator and drug delivery system, LungFit™ that uses NO generated from ambient air to deliver precise amounts of NO to the lungs for the potential treatment of a variety of pulmonary diseases. The LungFit™ delivery system can generate up to 400 ppm of NO.


Visit Website

Headquarters
Beyond Air Inc
825 East Gate Boulevard
Suite 320
Garden City
NY 11530
United States

Phone / Contact

T: +1-516-665-8200

Connect

Beyond Air is a clinical-stage medical device and biopharmaceutical company developing a NO generator and delivery system, LungFit™ that uses NO generated from ambient air to deliver precise amounts of NO to the lungs for the potential treatment of a variety of pulmonary diseases. The LungFit™ can generate up to 400 ppm of NO for delivery either continuously or for a fixed amount of time and has the ability to either titrate dose on demand or maintain a constant dose.  The company is currently applying its therapeutic expertise to develop treatments for pulmonary hypertension in various settings, in addition to treatments for lower respiratory tract infections that are not effectively addressed with current standards of care. Beyond Air is currently advancing its revolutionary LungFit™ in clinical trials for the treatment of bronchiolitis and severe lung infections such as nontuberculous mycobacteria (NTM).  Additionally, Beyond Air is using ultra-high concentrations of NO with a proprietary delivery system to target certain solid tumours in the preclinical setting.

Top